Gronau, Germany

Oskar Rohte

This inventor holds 2 USPTO granted patents. Top assignee: Other. Active years: 1980-1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Oskar Rohte. Retrieved from https://idiyas.com/inventor/oskar-rohte-eded5d79

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 27(Granted Patents)


Company Filing History:

goldMedal2 out of 834,570 
Other
 patents

Years Active: 1980-1981

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Oskar Rohte: Innovator in Vasodilator Research

Introduction

Oskar Rohte is a notable inventor based in Gronau, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of vasodilators. His work focuses on compounds that promote blood flow while maintaining low toxicity levels.

Latest Patents

Oskar Rohte holds 2 patents related to his research. His latest patents include "7-(Oxoalkyl)-1,3-di-n-iso-propyl xanthines and their production" and "7-(Oxoalkyl)-1,3-dialkyl xanthines, and medicaments containing them." These compounds are effective vasodilators, demonstrating marked activity in promoting blood flow through skeletal muscle.

Career Highlights

Throughout his career, Oskar has focused on the synthesis and application of xanthine derivatives. His innovative approach has led to the development of compounds that are not only effective but also exhibit low toxicity, making them suitable for therapeutic use.

Collaborations

Oskar has collaborated with notable colleagues in his field, including Gunther Brenner and Joachim E. Goring. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Oskar Rohte's contributions to the field of medicinal chemistry, particularly in the area of vasodilators, highlight his innovative spirit and dedication to improving therapeutic options. His work continues to influence the development of effective and safe medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…